Supplementary figure shows the impact of UBE2T on nucleolar function in IDH1/TP53-mutant glioma, suggesting significant implications for tumor progression.
Supplementary Figure S1: GBM30 cell information and knock-down efficiency validation.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: